The Patent Finder

Biotheranostics, Inc.

8 patents currently held · Updated Nov 22, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Jun 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 22, 2027.

Recent changes

  • 1 term has ended since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,856,533Predicting breast cancer treatment outcome
In force
 · High confidence
In forceHigh confidence
US 11,078,538Post-Treatment Breast Cancer Prognosis
In force
 · Medium confidence
In forceMedium confidence
US 12,460,265Post-Treatment Breast Cancer Prognosis
In force
 · Medium confidence
In forceMedium confidence
US 11,549,148Neuroendocrine Tumors
In force
 · Medium confidence
In forceMedium confidence
US 12,595,516Neuroendocrine Tumors
In force
 · Medium confidence
In forceMedium confidence
US 12,215,390Integration of Tumor Characteristics with Breast Cancer Index
In force
 · Medium confidence
In forceMedium confidence
US 10,253,369Predicting Likelihood of Response to Combination Therapy
In force
 · High confidence
In forceHigh confidence
US 11,530,448Integration of Tumor Characteristics with Breast Cancer Index
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 3 patents in force now held by others · 1 lapsed for an unpaid fee · 11 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 11 abandoned · 3 no status recorded

Showing 1 to 10 of 17, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/002,028Integration of Tumor Characteristics with Breast Cancer IndexDec 26, 2024Pending
17/854,909Identification of Tumors and TissuesJun 30, 2022Pending
17/513,640Predicting Breast Cancer RecurrenceOct 28, 2021Pending
17/502,355Oct 15, 2021No status recorded
16/701,000Dec 2, 2019No status recorded
16/404,424Grading of Breast CancerMay 6, 2019Abandoned
15/807,474Predicting Breast Cancer Treatment OutcomeNov 8, 2017Abandoned
15/582,125Determining Tumor OriginApr 28, 2017Abandoned
15/470,818Prostate Cancer Survival and RecurrenceMar 27, 2017Abandoned
14/483,108Predicting Breast Cancer RecurrenceSep 10, 2014Abandoned
10 of 17 applications shown.
Pro members see all 17 published applications.
Pro members: see all 17 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited